Next-Generation Neuromodulation

Some of the biggest advances in pain treatment are not drugs at all. Neuromodulation uses precisely placed electricity to change how pain signals travel — and over the past decade it has gone from a blunt instrument to something closer to a tuned one.

The old idea: cover the pain

Classic spinal cord stimulation puts a thin lead near the spinal cord and delivers pulses that create a gentle tingling, called paresthesia, over the painful area. It works partly through the spinal “gate” described in how pain works: activity on large nerve fibers helps close the gate on pain signals. It helps many people — but the tingling is a constant reminder, and the setting never changes as you move.

Stimulation you can’t feel

Newer high-frequency (10 kHz) stimulation relieves pain without producing any tingling at all. In 2021 the FDA approved a 10 kHz system specifically for painful diabetic neuropathy — the first spinal cord stimulator cleared for that condition — after a trial showed substantial, durable relief where medication had fallen short. Taking the paresthesia away also removed one of the therapy’s least comfortable features.

Stimulators that listen

The bigger leap is closed-loop stimulation. An FDA-approved system now measures the spinal cord’s own electrical response to each pulse — a signal called an ECAP — and adjusts the next pulse more than a hundred times a second. Instead of a fixed dose of electricity, the device keeps the stimulation on target as you move, cough, or shift position, and it outperformed conventional open-loop stimulation in testing. It is the difference between a thermostat and a stuck dial.

Aiming more precisely

Stimulation can also be pointed at exactly the right spot. Dorsal root ganglion (DRG) stimulation, FDA-approved in 2016, targets the small bundle of nerve cell bodies that serves one region of the body — which makes it valuable for focal, hard-to-treat pain such as complex regional pain syndrome, where it outperformed standard stimulation in the pivotal ACCURATE trial. Peripheral nerve stimulation goes further still, treating a single nerve near the source of the pain.

No surgery required

Not every approach needs an implant. Non-invasive brain stimulation — repetitive transcranial magnetic stimulation (rTMS) and transcranial direct-current stimulation (tDCS) — sends magnetic or electrical pulses through the scalp to the brain’s motor cortex. Studies suggest it can ease some drug-resistant nerve pain and fibromyalgia, though the evidence is still mixed and the technique is not yet a settled part of routine care. It is a frontier worth watching honestly, neither dismissed nor oversold.

The through-line

Across all of these, the direction is the same: away from one fixed setting for everyone, toward stimulation that is precise, sometimes invisible, and increasingly able to adjust itself to the person wearing it. See where each device sits among everything in development in the pain treatment pipeline.